1. Home
  2. PLRX vs GDOT Comparison

PLRX vs GDOT Comparison

Compare PLRX & GDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • GDOT
  • Stock Information
  • Founded
  • PLRX 2015
  • GDOT 1999
  • Country
  • PLRX United States
  • GDOT United States
  • Employees
  • PLRX N/A
  • GDOT N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • GDOT Finance: Consumer Services
  • Sector
  • PLRX Health Care
  • GDOT Finance
  • Exchange
  • PLRX Nasdaq
  • GDOT Nasdaq
  • Market Cap
  • PLRX 682.2M
  • GDOT 572.3M
  • IPO Year
  • PLRX 2020
  • GDOT 2010
  • Fundamental
  • Price
  • PLRX $11.07
  • GDOT $8.81
  • Analyst Decision
  • PLRX Strong Buy
  • GDOT Hold
  • Analyst Count
  • PLRX 7
  • GDOT 4
  • Target Price
  • PLRX $40.50
  • GDOT $10.75
  • AVG Volume (30 Days)
  • PLRX 544.0K
  • GDOT 537.4K
  • Earning Date
  • PLRX 02-26-2025
  • GDOT 02-25-2025
  • Dividend Yield
  • PLRX N/A
  • GDOT N/A
  • EPS Growth
  • PLRX N/A
  • GDOT N/A
  • EPS
  • PLRX N/A
  • GDOT N/A
  • Revenue
  • PLRX N/A
  • GDOT $1,629,683,000.00
  • Revenue This Year
  • PLRX N/A
  • GDOT N/A
  • Revenue Next Year
  • PLRX N/A
  • GDOT $10.91
  • P/E Ratio
  • PLRX N/A
  • GDOT N/A
  • Revenue Growth
  • PLRX N/A
  • GDOT 10.45
  • 52 Week Low
  • PLRX $10.22
  • GDOT $7.70
  • 52 Week High
  • PLRX $18.92
  • GDOT $13.58
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 36.41
  • GDOT 27.89
  • Support Level
  • PLRX $10.94
  • GDOT $8.68
  • Resistance Level
  • PLRX $12.70
  • GDOT $9.30
  • Average True Range (ATR)
  • PLRX 0.77
  • GDOT 0.36
  • MACD
  • PLRX -0.18
  • GDOT -0.10
  • Stochastic Oscillator
  • PLRX 4.69
  • GDOT 14.68

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

Share on Social Networks: